William Blair downgraded Avantor to Market Perform from Outperform without a price target. The company reported Q2 results that came in below expectations and reduced guidance for the second time this year, the analyst tells investors in a research note. The firm says its industry work at bioprocessing conferences over the last several months highlights a challenging competitive environment for the company, particularly in fluid management.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AVTR: